Jove
Visualize
Contact Us

Related Experiment Videos

[New diagnostic developments in infection serology]

W Sibrowski1, P Brauer

  • 1Institut für Transfusionsmedizin, Westfälischen Wilhelms-Universität, Münster.

Infusionstherapie Und Transfusionsmedizin
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reversibility of platelet P2Y12 inhibition by platelet supplementation: ex vivo and in vitro comparisons of prasugrel, clopidogrel and ticagrelor.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Self-reported health behaviour change in adults: analysis of the Canadian Community Health Survey 4.1.

Chronic diseases and injuries in Canada·2014
Same author

Detection of bacterial contamination in platelet concentrates by a sensitive flow cytometric assay (BactiFlow): a multicentre validation study.

Transfusion medicine (Oxford, England)·2012
Same author

Inter-laboratory comparison of different rapid methods for the detection of bacterial contamination in platelet concentrates.

Vox sanguinis·2011
Same author

The isotype of autoantibodies influences the phagocytosis of antibody-coated platelets in autoimmune thrombocytopenic purpura.

Scandinavian journal of immunology·2011
Same author

Further advancements in predicting adsorption equilibria using excess formalism: calculation of adsorption excesses at the liquid/solid interface.

Journal of colloid and interface science·2010
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

New diagnostic tests for hepatitis C virus (HCV) and human immunodeficiency virus (HIV) have improved blood transfusion safety. While HCV tests are highly effective, the HIV-p24 antigen test offers limited benefit in low-prevalence areas.

Area of Science:

  • Virology
  • Immunology
  • Public Health

Context:

  • Advancements in diagnostic methods for virus-transmitted diseases.
  • Enhancements in hemotherapy virus security.
  • Introduction of novel virus antigens for improved diagnostic accuracy.

Purpose:

  • To evaluate the impact of new diagnostic developments on hemotherapy virus security.
  • To assess the efficacy of enzyme immunoassays (EIAs) and recombinant immunoblot assays (RIBA) in hepatitis C virus (HCV) diagnostics.
  • To analyze the utility of the HIV-p24 antigen test for early human immunodeficiency virus (HIV) detection and its effect on virus security.

Summary:

  • Second-generation EIAs incorporating additional HCV antigens show increased sensitivity and specificity.
  • The recombinant immunoblot assay (RIBA) with four synthetic antigens remains a key confirmatory test for HCV.

Related Experiment Videos

  • The HIV-p24 antigen test aids in shortening the 'window period' for HIV-1 and HIV-2 diagnosis but has limited impact in low-prevalence settings.

    • Impact:

    • Significant improvement in virus security within hemotherapy practices.
    • Enhanced diagnostic capabilities for HCV, leading to more accurate screening and confirmation.
    • Potential for earlier HIV detection, though its effectiveness is context-dependent based on disease prevalence.